Gemphire Therapeutics Inc. Separation Agreements
5 Contracts & Agreements
- Separation and Release Agreement entered into on January 16, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price (Filed With SEC on January 18, 2023)
- Separation Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang (Filed With SEC on November 4, 2021)
- Separation and Release Agreement with Dr. Lee Golden dated as of September 21, 2018 (Filed With SEC on November 8, 2018)
- Separation and Release Agreement with Jeffrey S. Mathiesen dated as of September 21, 2018 (Filed With SEC on November 8, 2018)
- Separation and Release Agreement between Gemphire Therapeutics Inc. and Mina Sooch dated May 30, 2017 (Filed With SEC on August 14, 2017)
